Pediatrician intervention impacts parental smoking in cystic fibrosis, diabetes, and bronchiolitis

Abstract

Background: Child exposure to cigarette smoke is harmful. It should be reduced through parental smoking cessation interventions. The aim of our study was to determine the impact of simple advice provided by the pediatrician on the smoking habits of parents of children with cystic fibrosis (CF), diabetes mellitus (DM), and infants hospitalized for bronchiolitis.Methods: Parents were interviewed on their smoking habits. Smoking cessation advice was provided by the pediatrician. A new smoking habits assessment was done at 3 months by phone interviews.Results: A total of 260 parents were interviewed (91 in the CF group, 136 in the DM group, and 33 in the bronchiolitis group). A total of 70 parents were active smokers: 33% of parents of children with CF, 23.5% of parents of children with DM, and 24.2% for those with infants hospitalized for bronchiolitis (p = .42). In the CF group, smoking cessation had been significantly more frequently discussed with the medical team previously. A total of 67 smoking parents (95.7%) answered the 3-month assessment: 29.8% reported having started a smoking cessation process; 10.4% had quit smoking. The quitting rate was significantly higher in the groups of patients followed for a respiratory disorder (37.5% for bronchiolitis, 15% for CF vs. 0% for DM, p = .005). Conclusion:This study shows the important role that information and simple advice from pediatricians can have in initiating smoking cessation in parents of patients followed in specialized clinics or who are hospitalized, with a greater efficiency in parents of patients suffering from lung disorders.

Recent advances in the early treatment of cystic fibrosis: Bridging the gap to highly effective modulator therapy

“…140 It is important that pediatricians address ETS with parents, as smoking cessation counseling can be effective. 141 Other environmental exposures may also be relevant, as higher levels of air pollution are associated with earlier bacterial pathogen acquisition in CwCF. 142,143 1.9.16 | Health equity concerns in CF The effects of lower SES status have long been recognized as an independent risk factor for lower health-related quality of life outcomes in CF.…”

“…In older CwCF who have been prescribed tezacaftor‐ivacaftor (TEZ‐IVA), exposure to ETS essentially eliminated any measurable pulmonary benefit from the modulator 140 . It is important that pediatricians address ETS with parents, as smoking cessation counseling can be effective 141 . Other environmental exposures may also be relevant, as higher levels of air pollution are associated with earlier bacterial pathogen acquisition in CwCF 142,143 …”